Literature DB >> 19270120

Reduction of tumor necrosis factor alpha-inducing capacity of recombinant Lactobacillus casei via expression of Salmonella OmpC.

A Kajikawa1, S Igimi.   

Abstract

The insertion of a heterologous gene into commensal bacteria is a common technique to develop a delivery agent for vaccination and therapies, but the pleiotropic effects of genetic modifications need to be investigated before its use in practical applications. Although supplemental properties provided by the expression of heterologous antigens have been reported, the negative or side effects on the immune-modulating properties caused by recombination are barely understood. In the present study, we fortuitously found that the secretion of tumor necrosis factor alpha (TNF-alpha) from murine macrophages was reduced by recombinant Lactobacillus casei expressing Salmonella OmpC compared to the stimulation of TNF-alpha secretion by nonexpressing L. casei. This reduction could not be attributed to OmpC as a purified protein. The main component of the OmpC-expressing strain included in the attenuation of TNF-alpha release seemed to be the cell wall, which exhibited higher sensitivity against N-acetylmuramidase than that of nonexpressing strains. These results suggest that the recombinant strain expressing a specific heterologous antigen might be digested rapidly in macrophages and lose immune-stimulating capability at an early time point.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19270120      PMCID: PMC2681715          DOI: 10.1128/AEM.01916-08

Source DB:  PubMed          Journal:  Appl Environ Microbiol        ISSN: 0099-2240            Impact factor:   4.792


  35 in total

1.  Augmentation of T(H)-1 type response by immunoactive AT oligonucleotide from lactic acid bacteria via Toll-like receptor 9 signaling.

Authors:  Takeshi Shimosato; Haruki Kitazawa; Shinichiro Katoh; Masanori Tohno; Iliyan Dimitrov Iliev; Chiho Nagasawa; Toshiro Kimura; Yasushi Kawai; Tadao Saito
Journal:  Biochem Biophys Res Commun       Date:  2005-01-28       Impact factor: 3.575

2.  Oral immunization of mice with lactic acid bacteria producing Helicobacter pylori urease B subunit partially protects against challenge with Helicobacter felis.

Authors:  Blaise Corthésy; Soledad Boris; Patrick Isler; Corinne Grangette; Annick Mercenier
Journal:  J Infect Dis       Date:  2005-09-13       Impact factor: 5.226

3.  Instruments for oral disease-intervention strategies: recombinant Lactobacillus casei expressing tetanus toxin fragment C for vaccination or myelin proteins for oral tolerance induction in multiple sclerosis.

Authors:  C B Maassen; J D Laman; M J den Bak-Glashouwer; F J Tielen; J C van Holten-Neelen; L Hoogteijling; C Antonissen; R J Leer; P H Pouwels; W J Boersma; D M Shaw
Journal:  Vaccine       Date:  1999-04-23       Impact factor: 3.641

4.  Enhanced antiinflammatory capacity of a Lactobacillus plantarum mutant synthesizing modified teichoic acids.

Authors:  Corinne Grangette; Sophie Nutten; Emmanuelle Palumbo; Siegfried Morath; Corinna Hermann; Joelle Dewulf; Bruno Pot; Thomas Hartung; Pascal Hols; Annick Mercenier
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-28       Impact factor: 11.205

5.  Intranasal immunisation using recombinant Lactobacillus johnsonii as a new strategy to prevent allergic disease.

Authors:  Lorenz Scheppler; Monique Vogel; Pamela Marti; Lorenz Müller; Sylvia M Miescher; Beda M Stadler
Journal:  Vaccine       Date:  2005-01-19       Impact factor: 3.641

6.  Purification, toxicity, and antiendotoxin activity of polymyxin B nonapeptide.

Authors:  R L Danner; K A Joiner; M Rubin; W H Patterson; N Johnson; K M Ayers; J E Parrillo
Journal:  Antimicrob Agents Chemother       Date:  1989-09       Impact factor: 5.191

7.  Active protection of mice against Salmonella typhi by immunization with strain-specific porins.

Authors:  A Isibasi; V Ortiz-Navarrete; J Paniagua; R Pelayo; C R González; J A García; J Kumate
Journal:  Vaccine       Date:  1992       Impact factor: 3.641

8.  The anti-allergic effects of lactic acid bacteria are strain dependent and mediated by effects on both Th1/Th2 cytokine expression and balance.

Authors:  Daisuke Fujiwara; Sayo Inoue; Hideyuki Wakabayashi; Toshio Fujii
Journal:  Int Arch Allergy Immunol       Date:  2004-10-04       Impact factor: 2.749

9.  IL-10 inhibits cytokine production by activated macrophages.

Authors:  D F Fiorentino; A Zlotnik; T R Mosmann; M Howard; A O'Garra
Journal:  J Immunol       Date:  1991-12-01       Impact factor: 5.422

10.  Macrophage deactivation by interleukin 10.

Authors:  C Bogdan; Y Vodovotz; C Nathan
Journal:  J Exp Med       Date:  1991-12-01       Impact factor: 14.307

View more
  1 in total

Review 1.  Development of recombinant vaccines in lactobacilli for elimination of salmonella.

Authors:  Akinobu Kajikawa; Shizunobu Igimi
Journal:  Biosci Microflora       Date:  2011-11-17
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.